IBDEI1AV ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23028,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,23029,0)
 ;;=V16.0^^125^1400^7
 ;;^UTILITY(U,$J,358.3,23029,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23029,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,23029,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,23029,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,23030,0)
 ;;=V16.1^^125^1400^8
 ;;^UTILITY(U,$J,358.3,23030,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23030,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,23030,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,23030,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,23031,0)
 ;;=V19.6^^125^1400^1
 ;;^UTILITY(U,$J,358.3,23031,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23031,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,23031,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,23031,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,23032,0)
 ;;=V18.2^^125^1400^2
 ;;^UTILITY(U,$J,358.3,23032,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23032,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,23032,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,23032,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,23033,0)
 ;;=V17.5^^125^1400^4
 ;;^UTILITY(U,$J,358.3,23033,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23033,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,23033,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,23033,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,23034,0)
 ;;=V17.7^^125^1400^3
 ;;^UTILITY(U,$J,358.3,23034,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23034,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,23034,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,23034,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,23035,0)
 ;;=V19.0^^125^1400^5
 ;;^UTILITY(U,$J,358.3,23035,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23035,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,23035,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,23035,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,23036,0)
 ;;=V16.3^^125^1400^6
 ;;^UTILITY(U,$J,358.3,23036,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23036,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,23036,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,23036,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,23037,0)
 ;;=V16.41^^125^1400^9
 ;;^UTILITY(U,$J,358.3,23037,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23037,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,23037,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,23037,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,23038,0)
 ;;=V16.42^^125^1400^10
 ;;^UTILITY(U,$J,358.3,23038,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23038,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,23038,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,23038,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,23039,0)
 ;;=V16.43^^125^1400^11
 ;;^UTILITY(U,$J,358.3,23039,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23039,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,23039,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,23039,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,23040,0)
 ;;=V19.5^^125^1400^13
 ;;^UTILITY(U,$J,358.3,23040,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23040,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,23040,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,23040,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,23041,0)
 ;;=V19.2^^125^1400^14
 ;;^UTILITY(U,$J,358.3,23041,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23041,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,23041,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,23041,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,23042,0)
 ;;=V17.3^^125^1400^16
 ;;
 ;;$END ROU IBDEI1AV
